AARTI PHARMALABS
Back to All Ratios
|
AARTI PHARMALABS Last 5 Year EV/EBIT History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
EV/EBIT(x) | 13.16 | 9.55 | 1.53 | -3.76 |
What is the latest EV/EBIT ratio of AARTI PHARMALABS ?
Year | EV/EBIT |
---|---|
Mar2024 | 13.16 |
Mar2023 | 9.55 |
Mar2022 | 1.53 |
Mar2021 | -3.76 |
How is EV/EBIT of AARTI PHARMALABS Trending?
Years | EV/EBIT | % Change | |
---|---|---|---|
Mar2024 | 13.16 | 37.80 | |
Mar2023 | 9.55 | 524.18 | |
Mar2022 | 1.53 | Positive | |
Mar2021 | -3.76 | - |
Other Financial Ratios of AARTI PHARMALABS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹8,264.5 Cr | -3.4% | 1.7% | 54% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,219.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,227.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,643.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹125,541.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,063.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | -3.4% |
1.7% |
54% |
SENSEX | -1.2% |
-3% |
-0.2% |
You may also like the below Video Courses